Abate Kristin sold KPTI
October 16, 2026 · Form 4 insider transaction
Abate Kristin sold 4,788 shares of Karyopharm Therapeutics Inc. at $0.34 per share, a transaction worth $1.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,788
Price
$0.34
Total value
$1.6K
InsiderAbate Kristin
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 16, 2026
Filing dateOctober 19, 2026
Shares owned after18,616
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 27, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.